Erenumab-aooe 70MG/ML autoinjector 1ML erenumab-aooe 140MG/ML autoinjector 1ML
Ended Indefinite Delivery Contract Awarded Last action
- Contract number
- 36E79720D0006
- Awardee
-
Amgen USA Inc. UEI XPGNQMXHP493
- Awarding agency
-
National Acquisition Center
Headquarters, Department of Veterans Affairs
- Task orders
- 3 $88,022 obligated
Award facts
- Opportunity
-
- CGRP Agents (VA-19-00073181) Solicitation · 36E79719R0025 · Posted Sep 17, 2019
- CGRP Agents (VA-19-00073181) Award Notice · Posted Jan 6, 2020
- Combined order value
- $88,022 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling <1% used
- $58,968,306.00
- Award type
- Single award
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
The federal contract IDV awarded to Amgen USA Inc., a division of the biotechnology company Amgen Inc., is primarily focused on supplying calcitonin gene-related peptide (CGRP) agents to the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The original solicitation, RFP 36E79719R0025 issued by the VA National Acquisition Center, sought a one-year contract with four one-year option periods to provide Erenumab-aooe, Fremanezumab-vfrm, and Galcanezumab-gnlm in various dosages and package sizes, with an estimated annual usage of 86,148 doses for each item.
Under this IDV contract (36E79720D0006) with a ceiling value of $58.97 million, Amgen has received delivery orders to supply influenza vaccines to the VA, BOP, and other federal agencies. For example, Amgen provided AFLURIA QUADRIVALENT 0.5ML single-dose, pre-filled syringes to the VA's Veterans Integrated Service Network 5 and flu shots to staff at the Federal Correctional Institution Terminal Island operated by the BOP. These task orders demonstrate Amgen's role in supporting federal healthcare initiatives by delivering critical pharmaceutical products to various government customers.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Add Subcontract Plan | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Show all 19
Quick answers
Who was awarded contract 36E79720D0006?
36E79720D0006 was awarded to Amgen USA Inc. by National Acquisition Center (Headquarters) on February 26, 2020.
How much is contract 36E79720D0006 worth?
Orders under 36E79720D0006 have obligated $88,022. 36E79720D0006's own ceiling is $58,968,306.
How many orders have been placed under contract 36E79720D0006?
3 orders have been placed under 36E79720D0006, the latest on April 9, 2021.
Who can order from contract 36E79720D0006?
36E79720D0006 is a single award indefinite delivery contract.
Was contract 36E79720D0006 competed?
The extent of competition for 36E79720D0006 was full and open competition. The government received 2 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV